These findings raise the interesting possibility that targeting hnRNPA2B1 splicing in colon cancer can be a useful therapeutic strategy to induce apoptosis and restrain proliferation and tumor progression. This evidence concerns the gene HNRNPA2B1 and colonic neoplasm.